Nearly nine in 10 professionals who prescribed Mallinckrodt’s HP Acthar gel (repository corticotropin) to Medicare patients in 2015 received some compensation from the company, a new study by Oregon researchers…
Nearly nine in 10 professionals who prescribed Mallinckrodt’s HP Acthar gel (repository corticotropin) to Medicare patients in 2015 received some compensation from the company, a new study by Oregon researchers…
PhRMA, the Biotechnology Innovation Organization (BIO) and the State of Nevada agreed to dismiss a case regarding the constitutionality of a Nevada drug pricing law that required companies to disclose…
A former drug distributor filed a class action lawsuit against Novartis and Par Pharmaceuticals Friday, accusing the drugmakers of a pay-for-delay scheme to block generic competition for Novartis’ blood pressure…
The FDA’s Office of Prescription Drug Promotion issued an untitled letter to Pfizer for a misleading direct-to-consumer online video for its Estring (estradiol vaginal ring) treatment for moderate-to-severe painful sex…
The Federal Trade Commission is taking a victory lap after a federal judge ordered AbbVie to pay a record $448 million antitrust award over its handling of a testosterone replacement…
A heavily staffed FDA inspection of pharmaceutical giant Mylan’s manufacturing facility in Morgantown, West Virginia netted the company a lengthy Form 483 listing numerous deficiencies in the firm’s quality control…
The EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended nine drugs for approval or marketing authorization at its June meeting, including the EU’s first two CAR-T cell therapies.…
The U.S. Supreme Court agreed to hear Merck’s appeal of a ruling allowing hundreds of failure-to-warn lawsuits against the drugmaker to proceed. Source: Drug Industry Daily
In the wake of hundreds of healthcare fraud arrests by the Justice Department last week, FDA Commissioner Scott Gottlieb promised more inspections of compounding and outsourcing facilities that distribute products…